Japan Agency for Medical Research and Development
32
8
10
15
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 32 trials
100.0%
+13.5% vs industry average
19%
6 trials in Phase 3/4
0%
0 of 15 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (32)
A Phase 2 Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (OP-724-H201)
Role: collaborator
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Role: collaborator
Integrating Services for Noncommunicable Diseases in Continuum of Care for Mothers and Children
Role: collaborator
Obtain Safety and Effectiveness of CT-ACL001, a Regenerative Ligament Using Biological Tissue, in ACLR
Role: collaborator
Efficacy/Effectiveness, Safety, and Immunogenicity of LC16m8 Mpox Vaccine in Colombia
Role: collaborator
Satralizumab in the Treatment of Pulmonary Arterial Hypertension (SATISFY-JP Trial)
Role: collaborator
Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma
Role: collaborator
Clinical Trial of Targeted Alpha Therapy Using [At-211]PSMA-5 for Prostate Cancer
Role: collaborator
Study of a Tankyrase Inhibitor RK-582 for Patients With Unresectable Metastatic Colorectal Cancer
Role: collaborator
TNT of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer
Role: collaborator
Safety and Tolerability Study of OP-724 in Liver Cirrhosis Patients by HIV/HCV with Hemophilia.
Role: collaborator
Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis
Role: collaborator
Intracerebral Transplantation of Autologous MSC Combined With Scaffold Product for Chronic Intracerebral Hemorrhage
Role: collaborator
Investigator-initiated Clinical Trial of MIKE-1
Role: collaborator
The Bleeding With Antithrombotic Therapy Study 2
Role: collaborator
Randomized Phase IIb Trial of DVC1-0101
Role: collaborator
Phase I/II Study of COVID-19 DNA Vaccine (AG0302-COVID19 High-dose)
Role: collaborator
An Open Label, Single Arm, Dose Escalation Phase 1 Trial of PRI-724 in Patients With HCV-induced Cirrhosis
Role: collaborator
A Follow-up Evaluation Study of PRI-724-1101
Role: collaborator
Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I)
Role: collaborator